![Banner Hero RepTrak Rankings Company with fullcolor picture](https://images.ctfassets.net/az51l532ei6u/5kwNLXFzHaRHR0a2KW5MtL/67f08b436bae76f9629deac9b14ba9b1/Banner_Hero_RepTrak_Rankings_Company_with_fullcolor_picture.png?w=1680&h=500&q=100&fm=png)
Gilead Sciences
![gilead icon](https://images.ctfassets.net/az51l532ei6u/5UBpgQkiLdojiraHdbDSUr/0345c0ce31951c4a2ef5c51d325cec65/gileadicon.jpg?w=254&h=250&fl=progressive&q=50&fm=jpg)
![Placeholder Lifestyle](https://images.ctfassets.net/az51l532ei6u/42GgswicMfsWR1vRtUt4lG/acbf02b81cc29b00dc9f6ee6d8161dd4/Untitled_design__1_-page-001.jpg?w=2188&h=781&fl=progressive&q=50&fm=jpg)
![ESG Rankings Icon](https://images.ctfassets.net/az51l532ei6u/5ZL16DJeglmz3KBTrnyUde/8a84be874bbfa6edaa0701f07a55ac5c/ESG_Ranking_Blank.png?w=300&h=300&q=100&fm=png)
#6
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
2022 ESG Score
71.1
StrongStrong - Refers to a company that has achieved a reputation score within the 70–79-point range on a 0 – 100 scale. This is the second highest tier in our normative scale and is shown in light green.
- Poor 0-39
- Weak 40-59
- Average 60-69
- Strong 70-79
- Excellent 80+